Community pharmacies can use some rapid point-of-care C-19 antigen tests on patients with symptoms

Public Health England published new guidance on 1 February 2021, allowing community pharmacies to use rapid point-of-care COVID-19 antigen tests on patients with symptoms.

A valid CE mark will be required for any test used in pharmacies to guarantee that its manufacturing and design achieves the performance set for its purpose and is safe to use.

Chair of the English Pharmacy Board, Claire Anderson, stated: “We welcome the inclusion of pharmacy premises as a healthcare setting where a COVID-19 point of care or near person test, with a valid CE mark, may be used. Pharmacists can provide the essential advice and support required to use and interpret tests appropriately, ensuring that the public are aware of what steps they need to take following their result.”